Read more about Sebi eases listing rules for large IPOs, paving way for LIC s mega float on Business Standard. Lowers minimum dilution, extends deadline to increase float for big companies
The whistle-blower alleged that Sun Pharma and its subsidiary, Sun Pharmaceutical Laboratories, had diverted funds through Aditya Medisales, its sole distributor in India.
The Securities and Exchange Board of India (Sebi) on Wednesday imposed a penalty of Rs 1 crore on the National Stock Exchange (NSE) and Rs 25 lakh each on former heads Ravi Narain and Chitra Ramkrishna in a fresh order in the co-location case. The regulator dropped the allegations of fraudulent and unfair trade practices against NSE, Narain and Chitra and has charged them for violation of the Securities Contracts Stock Exchanges and Clearing Corporations (SECC) Regulations. The violation is of provisions pertaining to “equal, unrestricted, transparent and fair access to all persons without any bias.” “The violations in this case are serious in nature, even though there are no investor complaints on record arising out of such violations. Such nature of default with regard to non-adherence to the laid down obligations under the SECC Regulations as observed in this case would compromise the regulatory framework and should be dealt with by imposing monetary penalty on the no
Insider trading case: Future Group s Kishore Biyani moves SAT against Sebi ban
Sebi had banned Kishore Biyani, his brother Anil Biyani and Future Corporate Resources Limited (FCRL) from accessing the securities market for a period of 1 year
BusinessToday.In | February 6, 2021 | Updated 19:44 IST
Kishore Biyani moves SAT against Sebi order
Future Group s Kishore Biyani, his brother Anil Biyani and Future Corporate Resources Limited (FCRL) have moved the Securities Appellate Tribunal (SAT) against the Sebi order that barred them from the securities market.
Markets regulator Securities and Exchange Board of India (Sebi) on February 3 banned the Biyani bothers and FCRL from accessing the securities market for a period of 1 year. The regulator had also restrained Biyani from buying, selling or dealing in the securities of Future Retail Limited (FRL), directly or indirectly, in any manner whatsoever, for a period of 2 years. They were also asked to jointly and severally disgorge an